Evaluation of 5-aminoisoquinoline (5-AIQ), a novel PARP-1 inhibitor for genotoxicity potential in vitro and in vivo

References

• Ashby J, Tennant RW. 1988. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res 204:17–115.
   PubMed Web of Science ®Google Scholar
• Benigni R, Andreoli C, Giuliani A. 1994. QSAR models for both mutagenic potency and activity: application to nitroarenes and aromatic amines. Environ Mol Mutagen 24:208–219.
   PubMed Web of Science ®Google Scholar
• Benigni R, Passerini L, Gallo G, Giorgi F, Cotta-Ramusino M. 1998. QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines. Environ Mol Mutagen 32:75–83.
   PubMed Web of Science ®Google Scholar
• Colvin ME, Hatch FT, Felton JS. 1998. Chemical and biological factors affecting mutagen potency. Mutat Res 400:479–492.
   PubMed Web of Science ®Google Scholar
• Conde C, Mark M, Oliver FJ, Huber A, deMurcia G, Ménissier-de Murcia J. 2001. Loss of poly (ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J 20:3535–3543.
   PubMed Web of Science ®Google Scholar
• CSGMT (1988). The Collaborative Study Group for the Micronucleus Test Strain difference in the micronucleus test. Mutat Res. 204: 307–16.
   PubMedGoogle Scholar
• Debnath AK, Debnath G, Shusterman AJ, Hansch C. 1992. A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimurium TA 98 and TA 100. Environ Mol Mutagen 19:37–52.
   PubMed Web of Science ®Google Scholar
• deMurcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich ML, Walztinger C, Chambon P, deMurcia G. 1997. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303–7307.
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K, LaVoie EJ, Tulley-Freiler L, Hecht SS. 1981. Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes. Mutat Res 90:345–354.
   PubMedGoogle Scholar
• Gharat LK, Szallasi A. 2008. Advances in the design and therapeutic use of capsaicin receptor TRPV-1 agonist and antagonists. Expert Opin Ther Patents 18:159–209.
   Web of Science ®Google Scholar
• Hayashi M., Sofuni T.and Ishidate, M. (1982) High sensitivity in micronucleus induction of a mouse strain (MS). Mutat. Res. 105:253–256.
   PubMedGoogle Scholar
• Jagtap P, Szabo C. 2005. Poly (ADB-ribose) polymerase and the therapeutic effects of its inhibitors. Nature Rev 4:421–440.
   Web of Science ®Google Scholar
• Jetter MC, Youngman MA, McNally JJ. 2004. N-isoquinolin-5-yl-N’aralkyl—urea and amide antagonists of human vanilloid receptor 1. Bioorg Med Chem Lett 14:3053–3056.
   PubMed Web of Science ®Google Scholar
• Lai DY, Woo YT, Argus MF, Arcos JC. 1996. Cancer risk reduction through mechanism-based molecular design of chemicals. In: DeVito SC, Garrett RL, editors. Designing safer chemicals: Green chemistry for pollution prevention. Vol. 640. Washington, DC: ACS Symposium Series. pp 62–73.
   Google Scholar
• LaVoie EJ, Defauw J, Fealy M, Way BM, McQueen CA. 1991. Genotoxicity of fluoroquinolines and methylquinolines. Carcinogenesis 12:217–220.
   PubMed Web of Science ®Google Scholar
• LeFevre P, Ashby J. 1992. Mitogenic activity of quinoline to the rat, mouse and guinea pig liver. Environ Mol Mutagen 20:39–43.
   PubMed Web of Science ®Google Scholar
• Leong-Morgenthaler PM, Veli CO, Jaccaud E, Turesky RJ. 1998. Mutagenicity of 2-amino-3-methylimidazo [4,5-f] quinoline in human lymphoblastoid cells. Carcinogenesis 19:1749–1754.
   PubMed Web of Science ®Google Scholar
• Maron D, Ames BN. 1983. Revised methods for the Salmonella mutagenicity test. Muta. Res 113:173–215.
   Google Scholar
• Matsumoto T, Yoshida D, Mizusaki S, Tomita H,and Koshimizu K. 1978. Structural requirements for mutagenic activities of N-heterocyclic bases in the Salmonella test system. Agricul Biol Chem, 42: 861–864.
   Web of Science ®Google Scholar
• Moorehead PC, Nowell PC, Mellman WJ, Battips DM, Hemgerford DA. 1960. Chromosomal preparations of leucocytes cultured from human peripheral blood. Exp Cell Res 20:613–616.
   PubMed Web of Science ®Google Scholar
• Mota-Fillipe H, Sepodes B, McDonold M, Cuzzocrea S, Pinto R, Thiemermann C. 2002. The novel PARP inhibitor 5-aminoisoquinoline reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 8:444–453.
   Google Scholar
• OECD (Organization of Economic Development and Cooperation). 1997a. Genetic toxicology: Bacterial reverse mutation test. In OECD Guidelines for testing of chemicals, Test guideline 471. France: OECD.
   Google Scholar
• OECD (Organization of Economic Development and Cooperation). 1997b. Genetic toxicology: In vitro chromosome aberration test. In OECD Guidelines for testing of chemicals, Test guideline 473. France: OECD.
   Google Scholar
• OECD (Organization of Economic Development and Cooperation). 1997c. Genetic toxicology: In vivo micronucleus test. In OECD Guidelines for testing of chemicals, Test guideline 474. France: OECD.
   Google Scholar
• Pasqual MS, Lauer CP, Moyna P, Henriques JA. 1993. Genotoxicity of the isoquinoline alkaloid berberine in prokaryotic and eukaryotic organisms. Mutat Res 286:243–252.
   PubMedGoogle Scholar
• Radulovic S, Bjelogrlic S, Todorovic Z, Prostran M. 2006. Chemosensitization of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor 5- aminoisoquinoline (5-AIQ) on various melanoma cell lines. Abstract published in Proceedings of ASCO (American Society of Clinical Oncology). J Clin Oncol 24:12019.
   Google Scholar
• Reigh G, McMahon H, Ishizaki M, Ohara T, Shimane K, Esumi Y, Green C, Tyson C, Ninomiya S. 1996. Cytochrome P-450 species involved in the metabolism of quinoline. Carcinogenesis 17:1989–1996.
   PubMed Web of Science ®Google Scholar
• Saeki K, Takahashi K, Kawazoe Y. 1993. Metabolism of mutagenicity deprived 3-fluoroquinoline: comparison with mutagenic quinoline. Biol Pharm Bull 16:232–234.
   PubMed Web of Science ®Google Scholar
• Savaraj N, Liang J, Lu K, Feun LG, Hsu TC. 1989. Genotoxicity of [1H] benz[de] isoquinoline-1,3 [2H] dione, 5-amino-2-,[2-dimethylamino] ethyl] (BIDA) in human lymphocytes. Cancer Invest 7:117–121.
   PubMed Web of Science ®Google Scholar
• Schmid W. 1982. The micronucleus test: an in vivo bone marrow method. In: Hsu TC, editor. Cytogenetic assays of environmental mutagens. New Jersey: Allanheld, Osmun. pp 221–229.
   Google Scholar
• Skarek M, Cupr P, Reblova K, Damborsky J, Marsalek B, Holoubek I. 2003. Assessment of toxic and genotoxic effects of N-heterocyclic polyaromatic hydrocarbons with miniaturized in vitro screening bioassays. 1st Workshop on Persistant Toxic Substances Contamination of European Region, Brno, Czech Republic, 10–12 November, Poster No. V-122.
   Google Scholar
• Takahashi K, Kamiya M, Sengoku Y, Kohda K, Kawzoe Y. 1988. Deprivation of the mutagenicity property of quinoline: inhibition of mutagenic metabolism by fluorene substitution. Chem Pharm Bull 36:4630–4633.
   PubMed Web of Science ®Google Scholar
• Testa B, Caldwell. 1995. Monooxygenase-catalyzed nitrogen oxidations. In: The metabolism of drugs and other xenobiotics: Biochemistry of redox reactions. London: Academic Press. pp 186–187.
   Google Scholar
• Trieff NM, Biagi GL, Ramanujam VMS, Connor TH, Cantelli-Forti G, Guerra MC, Bunce H III, Legator MS. 1989. Aromatic amines and acetamides in Salmonella typhimurium TA 98 and TA 100: a quantitative structure-activity relation study. Mol Toxicol 2:53–65.
   PubMedGoogle Scholar
• USEPA (United States Environmental Protection Agency). 2001. Toxicological reviews of quinoline. EPA/635/R-01/005.
   Google Scholar
• Vodenicharov MD, Sallmann FR, Satoh MS, Poirier GG. 2000. Base excision repair is efficient in cells lacking poly(ADP-ribose) polymerase-1. Nucleic Acid Res 28:3887–3896.
   PubMed Web of Science ®Google Scholar